Thursday, January 31, 2013 Wednesday, January 30, 2013- FDA Approves Genzyme, Isis's Kynamroat Motley Fool (Wed, Jan 30)
- Isis Aces its Testat Motley Fool (Wed, Jan 30)
- 4 Healthcare Stock Stories for Wednesday Wellnessat Wall St. Cheat Sheet (Wed, Jan 30)
- Isis Jumps as FDA Clears Cholesterol Treatmentat Bloomberg (Wed, Jan 30)
- US Nod for ISIS/Sanofi's KynamroZacks (Wed, Jan 30)
- Why Isis Pharmaceuticals Shares Poppedat Motley Fool (Wed, Jan 30)
- Isis Pharmaceuticals' CEO Discusses Update on FDA Approval of KYNAMRO Conference Call (Transcript)at Seeking Alpha (Wed, Jan 30)
- Isis Pharma shares rise on Kynamro approvalAP (Wed, Jan 30)
- 3 Stocks on the Rise Despite Disappointing GDP Reportat Motley Fool (Wed, Jan 30)
- Isis Pharmaceuticals: A Compelling Long-Term Storyat Seeking Alpha (Wed, Jan 30)
- [video] Cramer's Six in 60: Salesforce.com, BP & Moreat CNBC (Wed, Jan 30)
- Isis Pharmaceuticals' Conference Call/Webcast to Provide Update on FDA Approval of KYNAMROT scheduled for 9:30 am ET todayCCBN (Wed, Jan 30)
- Isis and Sanofi's Drug OK'd to Treat Inherited Cholesterol Diseaseat Minyanville (Wed, Jan 30)
- Strong margins drive Amazon higheroptionMONSTER (Wed, Jan 30)
- Isis Pharmaceuticals: Kynamro's Approval Is An Antisense Home Run.at Seeking Alpha (Wed, Jan 30)
- After 24 Years Of Struggle, Has Stan Crooke Finally Birthed An Age Of Antisense?at Forbes (Wed, Jan 30)
- Aegerion CEO Speaks On Juxtapid Launch, Orphan Drug Pricing And Competitionat TheStreet (Wed, Jan 30)
- ISIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Jan 30)
Tuesday, January 29, 2013Add ISIS News to My Yahoo!   | |
|
0.08%